Old Web
English
Sign In
Acemap
>
authorDetail
>
Lichen L Teng
Lichen L Teng
Hoffmann-La Roche
Medicine
Physical therapy
Placebo
Randomized controlled trial
Adverse effect
4
Papers
353
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Longterm (52-week) Results of a Phase III Randomized, Controlled Trial of Apremilast in Patients with Psoriatic Arthritis
2015
The Journal of Rheumatology
Arthur Kavanaugh
Philip J. Mease
Juan Jesus Gomez-Reino
A. Adebajo
J. Wollenhaupt
Dafna D. Gladman
Marla Hochfeld
Lichen L Teng
Georg Schett
Eric Lespessailles
Stephen Hall
Show All
Source
Cite
Save
Citations (100)
Tocilizumab as monotherapy or in combination with nonbiologic disease-modifying antirheumatic drugs: twenty-four-week results of an open-label, clinical practice study.
2013
Arthritis Care and Research
Michael E. Weinblatt
Joel M. Kremer
John J. Cush
William F. C. Rigby
Lichen L Teng
Jenny Devenport
Natasha Singh
Denise Lepley
Mark C. Genovese
Show All
Source
Cite
Save
Citations (47)
Efficacy of tocilizumab in patients with moderate to severe active rheumatoid arthritis and a previous inadequate response to disease-modifying antirheumatic drugs: the ROSE study
2012
Annals of the Rheumatic Diseases
Yusuf Yazici
Jeffrey R. Curtis
Akgun Ince
Herbert F. Baraf
Raymond L Malamet
Lichen L Teng
Arthur Kavanaugh
Show All
Source
Cite
Save
Citations (105)
PHOENIX: A randomized controlled trial of peginterferon alfa-2a plus ribavirin as a prophylactic treatment after liver transplantation for hepatitis C virus†‡§¶
2011
Liver Transplantation
Natalie Bzowej
David R. Nelson
Norah A. Terrault
Gregory T. Everson
Lichen L Teng
Avinash Prabhakar
Michael R. Charlton
Show All
Source
Cite
Save
Citations (101)
1